ET-06 Suppression of glioblastoma through novel drug based on “Gene Switch Technology”

Glioblastoma (GBM) is the most common and aggressive malignancy primarily affecting adults. Despite intensive multimodal therapies, the prognosis of GBM is dismal and a novel therapy is needed. Here, we focused on RUNX, a transcription factor involved in the malignant transformation of GBM, and deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Etsuko, Arakawa, Yoshiki, Mineharu, Youhei, Mikami, Masamitsu, Matsui, Yasuzumi, Sugiyama, Hiroshi, Miyamoto, Susumu, Adachi, Souichi, Kamikubo, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699031/
http://dx.doi.org/10.1093/noajnl/vdaa143.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699031/
http://dx.doi.org/10.1093/noajnl/vdaa143.026

Ejemplares similares